Evidence map›Paper›PMID 28839280›Full record

ArticleScientific reports2017

The adjuvant value of Herba Cistanches when used in combination with statin in murine models.

Elaine Wat, Chun Fai Ng, Chi Man Koon, Cheng Zhang, Si Gao, Brian Tomlinson, Clara Bik San Lau

Open access · goldFull text read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Elaine WatInstitute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Chun Fai NgInstitute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Chi Man KoonInstitute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Cheng ZhangInstitute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Si GaoInstitute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Brian TomlinsonDivision of Clinical Pharmacology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Clara Bik San LauInstitute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong. claralau@cuhk.edu.hk.ORCID 0000-0002-7409-1270
Chinese University of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Statins are well known to have muscle toxicity problem. Herba Cistanches (HC) is a Chinese herb traditionally used for pain in the loins and knees. Our previous in vitro study suggested that it could protect against statin-induced muscle toxicity. However, its in vivo protective effect has never been investigated. The objective of this study was to determine if the aqueous extract of HC (HCE) could prevent simvastatin-induced muscle toxicity in rats, and whether HCE could also exert beneficial effects on reducing high-fat diet-induced hypercholesterolemia and elevated liver cholesterol, thereby reducing the dose of simvastatin when used in combined therapy. From our results, HCE significantly restored simvastatin-induced reduction in muscle weights and reduced elevated plasma creatine kinase in rats. HCE also improved simvastatin-induced reduction in muscle glutathione levels, muscle mitochondrial membrane potential, and reduced simvastatin-induced muscle inflammation. Furthermore, HCE could exert reduction on liver weight, total liver lipid levels and plasma lipid levels in high-fat-fed mice. In conclusion, our study provided in vivo evidence that HCE has potential protective effect on simvastatin-induced toxicity in muscles, and also beneficial effects on diet-induced non-alcoholic fatty liver and hyperlipidemia when being used alone or in combination with simvastatin at a reduced dose.

Indexed as

Adjuvants, PharmaceuticAnimalsBiomarkersCistancheCreatine KinaseGene Expression ProfilingGlutathione PeroxidaseHydroxymethylglutaryl-CoA Reductase InhibitorsHyperlipidemiasLipid MetabolismLiverMaleMembrane Potential, MitochondrialMiceMuscle, SkeletalPlant ExtractsAdjuvants, PharmaceuticBiomarkersCreatine KinaseGlutathione PeroxidaseHydroxymethylglutaryl-CoA Reductase InhibitorsPlant ExtractsProtective AgentsReactive Oxygen Species

Identifiers

PMID28839280
PMCPMC5570940
OpenAlexW2745555156

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.